Quadrant Capital Group LLC Charles River Laboratories International, Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 465 shares of CRL stock, worth $78,222. This represents 0.01% of its overall portfolio holdings.

Number of Shares

465

Previous 470 1.06%

Holding current value

$78,222

Previous $97,000 6.19%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$187.96 - $245.29 $939 - $1,226	-5 Reduced 1.06%	465 $91,000
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $3,459 - $4,648	-17 Reduced 3.49%	470 $127,000
Q4 2023 Feb 08, 2024	BUY	$164.52 - $238.84 $18,097 - $26,272	110 Added 29.18%	487 $115,000
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $1,166 - $1,305	-6 Reduced 1.57%	377 $73,000
Q2 2023 Aug 09, 2023	SELL	$183.71 - $210.25 $8,634 - $9,881	-47 Reduced 10.93%	383 $80,000
Q1 2023 May 11, 2023	SELL	$191.89 - $259.92 $10,937 - $14,815	-57 Reduced 11.7%	430 $86,000
Q3 2022 Nov 10, 2022	SELL	$182.44 - $250.54 $4,561 - $6,263	-25 Reduced 4.88%	487 $96,000
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $18,575 - $27,518	91 Added 21.62%	512 $110,000
Q1 2022 May 06, 2022	SELL	$255.51 - $362.11 $15,586 - $22,088	-61 Reduced 12.66%	421 $120,000
Q4 2021 Feb 01, 2022	SELL	$351.38 - $448.68 $7,027 - $8,973	-20 Reduced 3.98%	482 $182,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $9,688 - $11,915	26 Added 5.46%	502 $207,000
Q2 2021 Aug 09, 2021	BUY	$294.17 - $371.65 $4,412 - $5,574	15 Added 3.25%	476 $176,000
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $18,225 - $21,862	73 Added 18.81%	461 $134,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $3,996 - $4,547	-18 Reduced 4.43%	388 $97,000
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $24,362 - $38,892	-205 Reduced 33.55%	406 $71,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $21,758 - $39,234	220 Added 56.27%	611 $77,000
Q2 2019 Jul 24, 2019	SELL	$123.4 - $148.55 $40,105 - $48,278	-325 Reduced 45.39%	391 $52,000
Q1 2019 Apr 29, 2019	BUY	$104.82 - $146.73 $34,066 - $47,687	325 Added 83.12%	716 $100,000
Q3 2018 Oct 29, 2018	BUY	$112.11 - $134.54 $12,219 - $14,664	109 Added 38.65%	391 $50,000
Q3 2017 Oct 13, 2017	BUY	$96.72 - $109.26 $7,834 - $8,850	81 Added 40.3%	282 $27,000
Q2 2017 Aug 15, 2017	BUY	N/A	201	201 $14,000

Others Institutions Holding CRL

# of Institutions

691

Shares Held

52M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Charles River Laboratories International, Inc. Transaction History